Company · CIK 1492422
Apellis Pharmaceuticals, Inc.
| CIK | 1492422 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-12-20 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-269899 | 2023-02-22 | 2023-11-01 | 4 | |
| 333-235830 | 2020-01-07 | 2022-03-25 | 8 | |
| 333-229091 | 2018-12-28 | 2019-11-18 | 4 | |
| 333-224303 | 2018-04-16 | 2018-04-19 | 3 | |
| 333-220941 | 2017-10-13 | 2017-11-09 | 6 | |
| 333-207400 | 2015-10-13 | 2016-02-08 | 3 |
Filings
31| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-11-01 | 424B5Shelf takedown | 333-269899 | 0001193125-23-267738 |
| 2023-02-24 | 424B5Shelf takedown | 333-269899 | 0001193125-23-048395 |
| 2023-02-22 | 424B5Shelf takedown | 333-269899 | 0001193125-23-044169 |
| 2023-02-22 | S-3ASRShelf registered | 333-269899 | 0001193125-23-044140 |
| 2022-03-25 | 424B5Shelf takedown | 333-235830 | 0001193125-22-084189 |
| 2022-03-23 | 424B5Shelf takedown | 333-235830 | 0001193125-22-082865 |
| 2022-01-20 | 424B5Shelf takedown | 333-235830 | 0001193125-22-013844 |
| 2021-11-17 | 424B5Shelf takedown | 333-235830 | 0001193125-21-331991 |
| 2021-11-15 | 424B5Shelf takedown | 333-235830 | 0001193125-21-330175 |
| 2020-01-09 | 424B5Shelf takedown | 333-235830 | 0001193125-20-004806 |
| 2020-01-07 | 424B5Shelf takedown | 333-235830 | 0001193125-20-003041 |
| 2020-01-07 | S-3ASRShelf registered | 333-235830 | 0001193125-20-002991 |
| 2019-11-18 | EFFECTDeclared effective | 333-229091 | 9999999995-19-002593 |
| 2019-03-07 | 424B5Shelf takedown | 333-229091 | 0001193125-19-067261 |
| 2019-03-06 | 424B5Shelf takedown | 333-229091 | 0001193125-19-065578 |
| 2018-12-28 | S-3ASRShelf registered | 333-229091 | 0001193125-18-361002 |
| 2018-04-19 | 424B4Final prospectus | 333-224303 | 0001193125-18-122634 |
| 2018-04-18 | EFFECTDeclared effective | 333-224303 | 9999999995-18-000858 |
| 2018-04-16 | S-1Registration filed | 333-224303 | 0001193125-18-118655 |
| 2018-04-03 | DRSDraft made public | 377-02007 | 0000950123-18-003316 |
| 2017-11-09 | 424B4Final prospectus | 333-220941 | 0001193125-17-338588 |
| 2017-11-08 | EFFECTDeclared effective | 333-220941 | 9999999995-17-002925 |
| 2017-10-30 | S-1/AAmendment | 333-220941 | 0001193125-17-324222 |
| 2017-10-27 | S-1/AAmendment | 333-220941 | 0001193125-17-323102 |
| 2017-10-20 | S-1/AAmendment | 333-220941 | 0001193125-17-315537 |
| 2017-10-13 | S-1Registration filed | 333-220941 | 0001193125-17-309813 |
| 2017-08-30 | DRSDraft made public | 377-01698 | 0000950123-17-008317 |
| 2016-02-08 | RWWithdrawn | 333-207400 | 0001193125-16-453827 |
| 2015-11-02 | S-1/AAmendment | 333-207400 | 0001193125-15-362509 |
| 2015-10-13 | S-1Registration filed | 333-207400 | 0001193125-15-342824 |
| 2015-08-19 | DRSDraft made public | 377-01116 | 0000950123-15-009542 |